Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-001585

ChemoCentryx, Inc. · CCXI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Markus J. Cappel
Officer — Chief Bus. Officer & Treasurer
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 8:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 1, 2019M8,334$0.00A32,160D
Common StockJan 1, 2019M10,000$0.00A42,160D
Common StockJan 1, 2019M6,666$0.00A48,826D
Common StockF4Jan 1, 2019F13,385$10.91D35,441D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F6—Jan 1, 2019M8,334D——Common Stock8,3340D
Restricted Stock UnitsF5,F7—Jan 1, 2019M10,000D——Common Stock10,00010,000D
Restricted Stock UnitsF5,F8—Jan 1, 2019M6,666D——Common Stock6,66613,334D

Explanation of responses